Topics

APHINITY and ATEMPT: Treating Early-Stage HER2+ Breast Cancer

08:00 EST 10 Feb 2020 | MedPageToday

]]>(MedPage Today) -- New data for patients with HER2-positive early stage breast cancer were reported in two important studies at the recent 2019 San Antonio Breast Cancer Symposium. APHINITY compared chemotherapy plus trastuzumab (Herceptin) to...

Original Article: APHINITY and ATEMPT: Treating Early-Stage HER2+ Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "APHINITY and ATEMPT: Treating Early-Stage HER2+ Breast Cancer"

Quick Search

Relevant Topics

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...